Literature DB >> 21861133

The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles.

Jinmu Deng1, Qin Huang, Feng Wang, Yingjiang Liu, Zhibiao Wang, Zhigang Wang, Qingtao Zhang, Bo Lei, Yuan Cheng.   

Abstract

This research was designed to determine whether disrupting the blood-brain barrier (BBB) in rats by applying focused ultrasound (FUS) combined with microbubbles induced changes in the density of caveolae and/or the expression of the structural protein caveolin-1. To this end, two approaches were utilized. First, using enhanced magnetic resonance imaging, characteristics of BBB disruption induced by our specific FUS parameters and dose of microbubble were recorded, and the time after treatment when the BBB was the most permeable was determined. Second, rats were treated with FUS or microbubbles alone, both or neither, and a combination of Evans blue (EB) BBB permeability assays, streptavidin-peroxidase (SP) immunohistochemistry, western blot, and transmission electron microscopy (TEM) was employed to detect any changes in caveolae density and caveolin-1 expression at the previously determined time point when the BBB was the most permeable. The first set of studies revealed that our specific FUS parameters and dose of microbubbles were able to induce a transient, targeted, and reversible BBB opening in rats, and that the BBB was the most permeable 1 h after treatment with FUS and microbubbles. In the second set of experiments, the results of the SP immunohistochemistry, western blot, and TEM, taken together, revealed that caveolae and caveolin-1 were primarily localized in the brain microvascular endothelial cells of all of the rats regardless of treatment, and that caveolin-1 expression was highest in the rats treated with both FUS and microbubbles. In summary, treatment with FUS, in combination with a dose of microbubbles, can enhance BBB permeability through a caveolae-mediated transcellular approach by upregulating the expression level of caveolin-1 and, consequently, the amount of caveolae. This caveolin-1-mediated transcellular transport pathway may cooperate with other transport pathways to induce opening of the BBB. This research sheds light on the mechanism of a transient, targeted, and reversible opening of the BBB induced by FUS combined with microbubbles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861133     DOI: 10.1007/s12031-011-9629-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  41 in total

1.  Multiple domains of occludin are involved in the regulation of paracellular permeability.

Authors:  M S Balda; C Flores-Maldonado; M Cereijido; K Matter
Journal:  J Cell Biochem       Date:  2000-04       Impact factor: 4.429

2.  Sound scattering and localized heat deposition of pulse-driven microbubbles

Authors: 
Journal:  J Acoust Soc Am       Date:  2000-06       Impact factor: 1.840

Review 3.  Pathophysiology of blood-brain barrier breakdown.

Authors:  Sukriti Nag
Journal:  Methods Mol Med       Date:  2003

4.  Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery.

Authors:  Kullervo Hynynen; Nathan McDannold; Natalia Vykhodtseva; Scott Raymond; Ralph Weissleder; Ferenc A Jolesz; Nickolai Sheikov
Journal:  J Neurosurg       Date:  2006-09       Impact factor: 5.115

Review 5.  Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.

Authors:  R A Kroll; E A Neuwelt
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

Review 6.  The caveolae membrane system.

Authors:  R G Anderson
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 7.  Flow-mediated endothelial mechanotransduction.

Authors:  P F Davies
Journal:  Physiol Rev       Date:  1995-07       Impact factor: 37.312

8.  Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications.

Authors:  Kullervo Hynynen; Nathan McDannold; Nickolai A Sheikov; Ferenc A Jolesz; Natalia Vykhodtseva
Journal:  Neuroimage       Date:  2005-01-01       Impact factor: 6.556

9.  Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels.

Authors:  Jun Yu; Sonia Bergaya; Takahisa Murata; Ilkay F Alp; Michael P Bauer; Michelle I Lin; Marek Drab; Teymuras V Kurzchalia; Radu V Stan; William C Sessa
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

10.  Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation.

Authors:  Bernadet D M Meijering; Lynda J M Juffermans; Annemieke van Wamel; Rob H Henning; Inge S Zuhorn; Marcia Emmer; Amanda M G Versteilen; Walter J Paulus; Wiek H van Gilst; Klazina Kooiman; Nico de Jong; René J P Musters; Leo E Deelman; Otto Kamp
Journal:  Circ Res       Date:  2009-01-22       Impact factor: 17.367

View more
  47 in total

Review 1.  Ultrasound enhanced drug delivery to the brain and central nervous system.

Authors:  Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

2.  Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy.

Authors:  Tam Nhan; Alison Burgess; Eunice E Cho; Bojana Stefanovic; Lothar Lilge; Kullervo Hynynen
Journal:  J Control Release       Date:  2013-09-02       Impact factor: 9.776

Review 3.  Drug delivery across the blood-brain barrier using focused ultrasound.

Authors:  Alison Burgess; Kullervo Hynynen
Journal:  Expert Opin Drug Deliv       Date:  2014-03-20       Impact factor: 6.648

Review 4.  Focused ultrasound-mediated drug delivery through the blood-brain barrier.

Authors:  Alison Burgess; Kairavi Shah; Olivia Hough; Kullervo Hynynen
Journal:  Expert Rev Neurother       Date:  2015-05       Impact factor: 4.618

5.  Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound.

Authors:  Emmanuel Thévenot; Jessica F Jordão; Meaghan A O'Reilly; Kelly Markham; Ying-Qi Weng; Kevin D Foust; Brian K Kaspar; Kullervo Hynynen; Isabelle Aubert
Journal:  Hum Gene Ther       Date:  2012-10-15       Impact factor: 5.695

Review 6.  Noninvasive and targeted drug delivery to the brain using focused ultrasound.

Authors:  Alison Burgess; Kullervo Hynynen
Journal:  ACS Chem Neurosci       Date:  2013-02-04       Impact factor: 4.418

7.  Effects of hnRNP A2/B1 Knockdown on Inhibition of Glioblastoma Cell Invasion, Growth and Survival.

Authors:  Jinmu Deng; Song Chen; Feng Wang; Hongxin Zhao; Zongyi Xie; Zhongye Xu; Qingtao Zhang; Ping Liang; Xuan Zhai; Yuan Cheng
Journal:  Mol Neurobiol       Date:  2015-01-14       Impact factor: 5.590

Review 8.  Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound.

Authors:  Charissa Poon; Dallan McMahon; Kullervo Hynynen
Journal:  Neuropharmacology       Date:  2016-02-18       Impact factor: 5.250

Review 9.  Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.

Authors:  Muna Aryal; Costas D Arvanitis; Phillip M Alexander; Nathan McDannold
Journal:  Adv Drug Deliv Rev       Date:  2014-01-22       Impact factor: 15.470

Review 10.  Ultrasound-mediated drug delivery for cardiovascular disease.

Authors:  Jonathan T Sutton; Kevin J Haworth; Gail Pyne-Geithman; Christy K Holland
Journal:  Expert Opin Drug Deliv       Date:  2013-03-01       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.